CGS vs DOC

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

53MEDIUM

DOC

DOCTORCARE CDI 1:1 [DOC]

53MEDIUM

Score Breakdown

CGS DOC
Technical
62
48
Catalyst
50
50
Sentiment
50
50
Fundamental
95
88
Momentum
80
68
Risk Gate
50
50

Key Metrics

CGS Metric DOC
$372.8MMarket Cap$49.5M
89KAvg Volume (20d)206K
+0.0%Short InterestN/A
$2.97052-Week High$0.210
$1.21052-Week Low$0.080
+1.9%Daily Change+8.0%
$2.150Entry Price$0.135
+22.5%ROE+617.6%
+19.2%Profit Margin+3.0%

Active Signals

CGS Signals

Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Moderate P/S ratio (6.6x)
Moderate revenue growth (+12%)
Piotroski F-Score strong (8/9, low-confidence approx)

DOC Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Volume surging at 2.1x normal while price falls — heavy selling pressure
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
4C filed 2026-01-28
Low P/S ratio (1.3x)

Ask Scout AI to compare CGS and DOC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CGS Full Analysis → DOC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).